首页 > 最新文献

Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity最新文献

英文 中文
2022-VA-445-ESGO Anatomy of the presacral region 骶前区解剖
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.398
J. Laufer, S. Scasso, Alejandra Mansilla, Federico Fleitas, Camila Calleji
{"title":"2022-VA-445-ESGO Anatomy of the presacral region","authors":"J. Laufer, S. Scasso, Alejandra Mansilla, Federico Fleitas, Camila Calleji","doi":"10.1136/ijgc-2022-esgo.398","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.398","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90105062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1524-ESGO COVID-19 pandemic impact on the availability and implementation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) procedures in patients with peritoneal carcinomatosis at the Wroclaw comprehensive cancer centre – a single-centre study 2019冠状病毒病大流行对弗罗茨瓦夫综合癌症中心腹膜癌患者细胞减少手术和腹腔热化疗(CRS+HIPEC)程序的可用性和实施的影响——一项单中心研究
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-ESGO.460
K. Szewczyk, M. Jedryka, M. Bębenek
Introduction/Background‘The impact of the COVID-19 pandemic on the oncological care system’ report shows that the number of new diagnoses of malignant neoplasms in Poland has decreased by 20% and there has been a decrease by 10–15% in the area of oncological surgery procedures (https://www.zwrotnikraka.pl/influencing-pandemic-covid-19-na-system-oncological-care/). It is also known CRS+HIPEC procedures in the treatment of patients with primary and secondary peritoneal neoplasms have been performed in Poland in insufficient amounts for many years (http://www.chirurgia-onkologiczna.pl/images/files/hipec.pdf). The aim of the study was to analyse the changes in the availability and implementation of CRS+HIPEC procedures performed at the Wroclaw Comprehensive Cancer Center (WCCC) Poland, during the COVID-19 pandemic.MethodologyDemographic, clinical, oncological and technical aspects database of all CCCW patients undergoing the CRS+HIPEC procedure was created. Statistical analysis of the data was carried out using the Statistica version 12.5 (StatSoft) program, with particular emphasis on the period of the COVID-19 pandemic (from 03.2020).ResultsIn the period from 01.2014 to 04.2022, a total of 232 CRS+HIPEC procedures were performed at CCCW, on average 28 per year (range 20–37). During the COVID-19 pandemic (from 03.2020), after the initial complete suspension of CRS+HIPEC procedures (03–05.2020), their dynamic growth occurred – 72 procedures were performed in the period 06.2020 – 04.2022 in total. The main indications were ovarian (40%) and colorectal (39%) cancers. During the COVID-19 pandemic, the Clavien-Dindo grade III and IV complication rate (14%) did not change, and there were no perioperative deaths recorded.ConclusionIn the era of the COVID-19 pandemic, CRS+HIPEC procedures remain a safe and promising therapeutic option for selected patients with primary and secondary peritoneal cancers.
“2019冠状病毒病大流行对肿瘤护理系统的影响”报告显示,波兰新诊断的恶性肿瘤数量减少了20%,肿瘤手术程序领域减少了10-15% (https://www.zwrotnikraka.pl/influencing-pandemic-covid-19-na-system-oncological-care/)。在波兰,CRS+HIPEC手术治疗原发性和继发性腹膜肿瘤患者的数量不足已持续多年(http://www.chirurgia-onkologiczna.pl/images/files/hipec.pdf)。该研究的目的是分析2019冠状病毒病大流行期间波兰弗罗茨瓦夫综合癌症中心(WCCC) CRS+HIPEC手术的可用性和实施情况的变化。方法对所有行CRS+HIPEC手术的CCCW患者建立人口统计学、临床、肿瘤学和技术方面的数据库。使用Statistica 12.5版(StatSoft)程序对数据进行统计分析,特别强调了COVID-19大流行期间(从2020年3月3日开始)。结果2014年1月至2022年4月,CCCW共进行CRS+HIPEC手术232例,平均每年28例(范围20 ~ 37例)。在2019冠状病毒病大流行期间(从2020年3月3日开始),CRS+HIPEC手术最初完全暂停(2020年5月3日至5月3日)后,它们出现了动态增长,在2020年6月至2022年4月期间共进行了72次手术。主要适应症为卵巢癌(40%)和结直肠癌(39%)。在COVID-19大流行期间,Clavien-Dindo III级和IV级并发症发生率(14%)没有变化,无围手术期死亡记录。结论在COVID-19大流行时代,CRS+HIPEC手术仍然是原发性和继发性腹膜癌患者安全且有前景的治疗选择。
{"title":"2022-RA-1524-ESGO COVID-19 pandemic impact on the availability and implementation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) procedures in patients with peritoneal carcinomatosis at the Wroclaw comprehensive cancer centre – a single-centre study","authors":"K. Szewczyk, M. Jedryka, M. Bębenek","doi":"10.1136/ijgc-2022-ESGO.460","DOIUrl":"https://doi.org/10.1136/ijgc-2022-ESGO.460","url":null,"abstract":"Introduction/Background‘The impact of the COVID-19 pandemic on the oncological care system’ report shows that the number of new diagnoses of malignant neoplasms in Poland has decreased by 20% and there has been a decrease by 10–15% in the area of oncological surgery procedures (https://www.zwrotnikraka.pl/influencing-pandemic-covid-19-na-system-oncological-care/). It is also known CRS+HIPEC procedures in the treatment of patients with primary and secondary peritoneal neoplasms have been performed in Poland in insufficient amounts for many years (http://www.chirurgia-onkologiczna.pl/images/files/hipec.pdf). The aim of the study was to analyse the changes in the availability and implementation of CRS+HIPEC procedures performed at the Wroclaw Comprehensive Cancer Center (WCCC) Poland, during the COVID-19 pandemic.MethodologyDemographic, clinical, oncological and technical aspects database of all CCCW patients undergoing the CRS+HIPEC procedure was created. Statistical analysis of the data was carried out using the Statistica version 12.5 (StatSoft) program, with particular emphasis on the period of the COVID-19 pandemic (from 03.2020).ResultsIn the period from 01.2014 to 04.2022, a total of 232 CRS+HIPEC procedures were performed at CCCW, on average 28 per year (range 20–37). During the COVID-19 pandemic (from 03.2020), after the initial complete suspension of CRS+HIPEC procedures (03–05.2020), their dynamic growth occurred – 72 procedures were performed in the period 06.2020 – 04.2022 in total. The main indications were ovarian (40%) and colorectal (39%) cancers. During the COVID-19 pandemic, the Clavien-Dindo grade III and IV complication rate (14%) did not change, and there were no perioperative deaths recorded.ConclusionIn the era of the COVID-19 pandemic, CRS+HIPEC procedures remain a safe and promising therapeutic option for selected patients with primary and secondary peritoneal cancers.","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84752655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-VA-887-ESGO A novel endoscopic surgery method: transurethral surgery – natural orifice translumenal endoscopic surgery (TUS-NOTES) using pneumocystoscopy for treatment of vesicovaginal fistula 一种新的内窥镜手术方法:经尿道手术-自然孔腔内窥镜手术(TUS-NOTES)使用肺膀胱镜治疗膀胱阴道瘘
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.416
J. Neymeyer, S. Weinberger, T. Schlomm
a conservative surgical approach with adjuvant thyroidectomy and radioactive therapy seems a rea-sonable approach and is supported by the relevant literature
保守手术加辅助甲状腺切除术和放疗似乎是一种合理的方法,并得到相关文献的支持
{"title":"2022-VA-887-ESGO A novel endoscopic surgery method: transurethral surgery – natural orifice translumenal endoscopic surgery (TUS-NOTES) using pneumocystoscopy for treatment of vesicovaginal fistula","authors":"J. Neymeyer, S. Weinberger, T. Schlomm","doi":"10.1136/ijgc-2022-esgo.416","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.416","url":null,"abstract":"a conservative surgical approach with adjuvant thyroidectomy and radioactive therapy seems a rea-sonable approach and is supported by the relevant literature","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83038709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1693-ESGO Breast carcinoma arising within fibroadenomas: report of seven observations 纤维腺瘤中发生的乳腺癌:七个观察报告
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.476
A. Jellali, Lamia Naija, Nayssem Khessairi, Takoua Chalouati, F. Saadallah, S. Kammoun, R. Chargui, K. Rahal
{"title":"2022-RA-1693-ESGO Breast carcinoma arising within fibroadenomas: report of seven observations","authors":"A. Jellali, Lamia Naija, Nayssem Khessairi, Takoua Chalouati, F. Saadallah, S. Kammoun, R. Chargui, K. Rahal","doi":"10.1136/ijgc-2022-esgo.476","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.476","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74319052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1001-ESGO Analysis of postoperative wound infections in malignancies of the female internal tract 女性消化道恶性肿瘤术后创面感染分析
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.424
Laura E. Eisenhardt, C. Brambs, K. Rothe
{"title":"2022-RA-1001-ESGO Analysis of postoperative wound infections in malignancies of the female internal tract","authors":"Laura E. Eisenhardt, C. Brambs, K. Rothe","doi":"10.1136/ijgc-2022-esgo.424","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.424","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75315505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-786-ESGO Angiomyxoma aggressivum – surgical complete resection of extremaly rare tumor of perineum 侵袭性血管粘液瘤-会阴极端罕见肿瘤的手术完全切除
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.407
M. Jedryka, Andrzej Czekański, P. Lepka, M. Ziętek
{"title":"2022-RA-786-ESGO Angiomyxoma aggressivum – surgical complete resection of extremaly rare tumor of perineum","authors":"M. Jedryka, Andrzej Czekański, P. Lepka, M. Ziętek","doi":"10.1136/ijgc-2022-esgo.407","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.407","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73141142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-705-ESGO Ovarian Leydig Cell Tumor: Cause of Virilization in a Postmenopausal Woman 卵巢间质细胞肿瘤:绝经后妇女男性化的原因
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.403
M. Garci, Siham Bouzidi, Sawssem Armi, C. Belghith, O. Slimani, N. Mathlouthi
{"title":"2022-RA-705-ESGO Ovarian Leydig Cell Tumor: Cause of Virilization in a Postmenopausal Woman","authors":"M. Garci, Siham Bouzidi, Sawssem Armi, C. Belghith, O. Slimani, N. Mathlouthi","doi":"10.1136/ijgc-2022-esgo.403","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.403","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78654211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-871-ESGO Retrospective analysis of patients with leiomyosarcoma in a tertiary hospital and comparative between incidental and suspected diagnosis 某三级医院平滑肌肉瘤患者的回顾性分析及偶然诊断与疑似诊断的比较
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.414
María Ruiz Minaya, Juan Manuel Pina Moreno, E. M. Mendizabal Vicente, W. Jiménez, S. Bonelli, Juan Antonio Leon Luis
{"title":"2022-RA-871-ESGO Retrospective analysis of patients with leiomyosarcoma in a tertiary hospital and comparative between incidental and suspected diagnosis","authors":"María Ruiz Minaya, Juan Manuel Pina Moreno, E. M. Mendizabal Vicente, W. Jiménez, S. Bonelli, Juan Antonio Leon Luis","doi":"10.1136/ijgc-2022-esgo.414","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.414","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78058918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1410-ESGO The new algorithm for the risk assessment in uterine lesions (R.A.U.L) 子宫病变风险评估新算法(R.A.U.L)
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.450
A. D. Cello, M. Borelli, M. Franzon, F. Zullo
{"title":"2022-RA-1410-ESGO The new algorithm for the risk assessment in uterine lesions (R.A.U.L)","authors":"A. D. Cello, M. Borelli, M. Franzon, F. Zullo","doi":"10.1136/ijgc-2022-esgo.450","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.450","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79171205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial 2022-RA-638-ESGO Pembrolizumab联合多模态免疫调节治疗化疗前宫颈癌、子宫内膜癌和子宫癌:PRIMMO II期试验
Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.401
E. D. De Jaeghere, S. Tuyaerts, A. V. Van Nuffel, A. Belmans, K. Bogaerts, R. Baiden-Amissah, P. Vuylsteke, S. Henry, X. Trinh, P. V. van Dam, S. Aspeslagh, A. De Caluwé, E. Naert, D. Lambrechts, A. Hendrix, O. De Wever, K. K. van de Vijver, F. Amant, K. Vandecasteele, H. Denys
{"title":"2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial","authors":"E. D. De Jaeghere, S. Tuyaerts, A. V. Van Nuffel, A. Belmans, K. Bogaerts, R. Baiden-Amissah, P. Vuylsteke, S. Henry, X. Trinh, P. V. van Dam, S. Aspeslagh, A. De Caluwé, E. Naert, D. Lambrechts, A. Hendrix, O. De Wever, K. K. van de Vijver, F. Amant, K. Vandecasteele, H. Denys","doi":"10.1136/ijgc-2022-esgo.401","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.401","url":null,"abstract":"","PeriodicalId":80519,"journal":{"name":"Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86950391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archaeologia aeliana, or, Miscellaneous tracts relating to antiquity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1